Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus.

CONCLUSION: Together, our data support that tedizolid has the potential to improve outcomes of infection due to its superior ability to inhibit S. aureus growth and attenuate exotoxin production.
PMID: 30556803 [PubMed - as supplied by publisher]

Source: Journal of Medical Microbiology - December 17, 2018 Category: Microbiology Authors: Katahira EJ, Davidson SM, Stevens DL, Bolz DD Tags: J Med Microbiol Source Type: research